82 related articles for article (PubMed ID: 8843228)
21. Suppression of adult T cell leukemia-derived factor/human thioredoxin induction by FK506 and cyclosporin A: a new mechanism of immune modulation via redox control.
Furuke K; Nakamura H; Hori T; Iwata S; Maekawa N; Inamoto T; Yamaoka Y; Yodoi J
Int Immunol; 1995 Jun; 7(6):985-93. PubMed ID: 7577807
[TBL] [Abstract][Full Text] [Related]
22. Molecular and biological actions of cyclosporin A and FK506 on T cell development and function.
Holländer GA; Bierer BE; Burakoff SJ
Transfus Sci; 1994 Sep; 15(3):207-20. PubMed ID: 10155542
[TBL] [Abstract][Full Text] [Related]
23. Effect of FK506 on the interleukin 15-driven proliferation and apoptosis of anti-CD3-activated umbilical cord blood T cells.
Lin SJ; Yan DC; Kuo ML; Cheng PJ; Hsiao SS; Tsai TL
Ann Allergy Asthma Immunol; 2005 Dec; 95(6):586-92. PubMed ID: 16400900
[TBL] [Abstract][Full Text] [Related]
24. Superior T-cell suppression by rapamycin and FK506 over rapamycin and cyclosporine A because of abrogated cytotoxic T-lymphocyte induction, impaired memory responses, and persistent apoptosis.
Koenen HJ; Michielsen EC; Verstappen J; Fasse E; Joosten I
Transplantation; 2003 May; 75(9):1581-90. PubMed ID: 12792519
[TBL] [Abstract][Full Text] [Related]
25. Cyclosporine A and FK506 show similar immunosuppressive effects on long-term in vitro T-cell proliferation.
Bruserud O; Pawelec G
Int J Immunopharmacol; 1993 Feb; 15(2):93-7. PubMed ID: 7682202
[TBL] [Abstract][Full Text] [Related]
26. Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell level.
Andersson J; Nagy S; Groth CG; Andersson U
Immunology; 1992 Jan; 75(1):136-42. PubMed ID: 1371491
[TBL] [Abstract][Full Text] [Related]
27. Expression of CD25 defines peripheral blood mononuclear cells with productive versus latent HIV infection.
Borvak J; Chou CS; Bell K; Van Dyke G; Zola H; Ramilo O; Vitetta ES
J Immunol; 1995 Sep; 155(6):3196-204. PubMed ID: 7673732
[TBL] [Abstract][Full Text] [Related]
28. Role of calcineurin in the regulation of human lung mast cell and basophil function by cyclosporine and FK506.
Harrison CA; Bastan R; Peirce MJ; Munday MR; Peachell PT
Br J Pharmacol; 2007 Feb; 150(4):509-18. PubMed ID: 17200674
[TBL] [Abstract][Full Text] [Related]
29. Influence of immunosuppressive agents on tryptophan degradation and neopterin production in human peripheral blood mononuclear cells.
Schroecksnadel S; Sucher R; Kurz K; Fuchs D; Brandacher G
Transpl Immunol; 2011 Sep; 25(2-3):119-23. PubMed ID: 21742032
[TBL] [Abstract][Full Text] [Related]
30. Regulation of interleukin-5 production by peripheral blood mononuclear cells from atopic patients with FK506, cyclosporin A and glucocorticoid.
Mori A; Suko M; Nishizaki Y; Kaminuma O; Matsuzaki G; Ito K; Etoh T; Nakagawa H; Tsuruoka N; Okudaira H
Int Arch Allergy Immunol; 1994; 104 Suppl 1(1):32-5. PubMed ID: 7512393
[TBL] [Abstract][Full Text] [Related]
31. Immunomodulatory effects of three macrolides, midecamycin acetate, josamycin, and clarithromycin, on human T-lymphocyte function in vitro.
Morikawa K; Oseko F; Morikawa S; Iwamoto K
Antimicrob Agents Chemother; 1994 Nov; 38(11):2643-7. PubMed ID: 7532933
[TBL] [Abstract][Full Text] [Related]
32. FK506 inhibits prostaglandin E2 production from synovial cells by suppressing peripheral blood mononuclear cells.
Sasakawa T; Sasakawa Y; Ohkubo Y; Mutoh S
Int Immunopharmacol; 2005 Jul; 5(7-8):1291-7. PubMed ID: 15914333
[TBL] [Abstract][Full Text] [Related]
33. Enhanced TARC production by dust-mite allergens and its modulation by immunosuppressive drugs in PBMCs from patients with atopic dermatitis.
Furukawa H; Nakamura K; Zheng X; Tojo M; Oyama N; Akiba H; Nishibu A; Kaneko F; Tsunemi Y; Saeki H; Tamaki K
J Dermatol Sci; 2004 Jun; 35(1):35-42. PubMed ID: 15194145
[TBL] [Abstract][Full Text] [Related]
34. FK506: an immunosuppressive agent preserving HIF-1 activity.
Kim KE; Jung YJ; Yeo EJ; Chun YS; Park JW
Immunopharmacol Immunotoxicol; 2006; 28(4):609-20. PubMed ID: 17190738
[TBL] [Abstract][Full Text] [Related]
35. Rapamycin, but not cyclosporine or FK506, alters natural killer cell function.
Wai LE; Fujiki M; Takeda S; Martinez OM; Krams SM
Transplantation; 2008 Jan; 85(1):145-9. PubMed ID: 18192925
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of human immunodeficiency virus replication by nonimmunosuppressive analogs of cyclosporin A.
Bartz SR; Hohenwalter E; Hu MK; Rich DH; Malkovsky M
Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5381-5. PubMed ID: 7777516
[TBL] [Abstract][Full Text] [Related]
37. Tacrolimus and cyclosporine A inhibit allostimulatory capacity and cytokine production of human myeloid dendritic cells.
Szabo G; Gavala C; Mandrekar P
J Investig Med; 2001 Sep; 49(5):442-9. PubMed ID: 11523700
[TBL] [Abstract][Full Text] [Related]
38. Cyclosporin A and FK506 reduce interleukin-5 mRNA abundance by inhibiting gene transcription.
Rolfe FG; Valentine JE; Sewell WA
Am J Respir Cell Mol Biol; 1997 Aug; 17(2):243-50. PubMed ID: 9271313
[TBL] [Abstract][Full Text] [Related]
39. Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patients.
Fukudo M; Yano I; Masuda S; Fukatsu S; Katsura T; Ogura Y; Oike F; Takada Y; Tanaka K; Inui K
Clin Pharmacol Ther; 2005 Aug; 78(2):168-81. PubMed ID: 16084851
[TBL] [Abstract][Full Text] [Related]
40. Highly purified CD25- resting T cells cannot be infected de novo with HIV-1.
Chou CS; Ramilo O; Vitetta ES
Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1361-5. PubMed ID: 9037058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
